Undersøgelse med raske frivillige har vist, at tolcapon reversibelt hæmmer erytrocyt- COMT- aktivitet efter oral administration.
Studies in healthy volunteers have shown that tolcapone reversibly inhibits human erythrocyte COMT activity after oral administration.